What is intravenous immunoglobulin (IVIG) therapy and what types of autoimmune disease is it used to treat? IVIG is a hugely successful biological with FDA approval for treating idiopathic ...

"[O]ur study, which has the largest cohort to date, did not show an increased rate of VTEs in patients with DM on IVIG. Therefore, it is safe to start patients on this medicine as it is one of our ...

Neurologist Susan W. Lee, DO, answers common questions about this treatment option for myasthenia gravis. Intravenous immunoglobulin (IVIG) is a pooled collection of antibodies derived from donors’ ...

A 52-year-old gentleman, who had been suffering from severe stiffness and difficulty walking for months, has shown a remarkable improvement following treatment with intravenous immunoglobulin (IVIG) ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Did you know that a component of your blood could be used ...

Prepared from the collective plasma of several thousand people, therapeutic intravenous immunoglobulin (IVIg) consists mostly of human polyspecific IgG. In addition to its use in primary and secondary ...

Jeffrey V. Ravetch (left) and Andrew T. Jones (right) showed that the anti-inflammatory activity of IgG is enhanced by co-engagement of type I and II ...

Please provide your email address to receive an email when new articles are posted on . In a case study of three patients with COVID-19 vaccine-induced immune thrombotic thrombocytopenia, starting ...

Prophylactic intravenous immunoglobulin reduces COVID-19 infection rates in older patients with DLBCL with hypogammaglobulinemia undergoing reduced-intensity R-CHOP therapy. The study, conducted ...

June 5, 2002 -- Intravenous immunoglobulin (IVIG) is effective in treating some forms of diabetic-related neuropathy, according to results of a study published in the May issue of the Archives of ...

The IVIG products gained significant attention in the recent years due to their high efficacy in the treatment of immune diseases. PORTLAND, OREGON, UNITED STATES, September 9, 2022 /EINPresswire.com ...